Status:
COMPLETED
Safety and Bioavailability of Micellar Green Tea Extract
Lead Sponsor:
Isura
Conditions:
Bioavailability and Pharmacokinetics
Safety
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
This study seeks to determine the short-term effects of daily oral supplementation of LipoMicel Green Tea on oral absorption and safety of green tea in healthy volunteers. The primary objective is to...
Eligibility Criteria
Inclusion
- male or female aged 21-65 years
- healthy, good physical condition
- voluntary, written, informed consent to participate in the study.
Exclusion
- use of anti-inflammatory or non-steroidal anti-inflammatory drugs
- previous history of cardiovascular disease or acute or chronic inflammatory disease
- use of antioxidant supplements or cholesterol-lowering agents
- change of diet habits or lifestyle (diet, physical activity, etc.)
- alcohol or substance abuse history
- use of nicotine or tobacco
- participation in another investigational study
Key Trial Info
Start Date :
December 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2025
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT06971536
Start Date
December 10 2023
End Date
March 30 2025
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ISURA
Burnaby, British Columbia, Canada